Child-inspired chemo shows promise for adult leukemia patients
NCT ID NCT01920737
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 36 times
Summary
This study tests whether a chemotherapy plan used for children with acute lymphoblastic leukemia (ALL) is safe and works well for adults aged 18 to 60 with a specific type of ALL (Ph-negative). The goal is to see if this approach can clear the disease from the bone marrow. About 39 adults are taking part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Medical Center
Durham, North Carolina, 27701, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Weill Cornell Medical Center
New York, New York, United States
Conditions
Explore the condition pages connected to this study.